💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Eagle Pharmaceuticals, Inc. (EGRX)
« Back to company indexEGRX Chatter Timeline
Stock Ticker for EGRX
Most Active Tweeters for EGRX
| User | Tweets |
|---|---|
| @TortozaLeandro | 8 |
| @Tickeron | 4 |
| @MaiteMerenda | 3 |
| @Ba4Saso | 2 |
| @FlashAlert_me | 2 |
Recent Tweets for EGRX
 |
@TortozaLeandro $EGRX Awaiting for Buy signal on EGRX with https://t.co/BVorhZSlcz https://t.co/j2AYhdsvXH January 25th 2022, 7:01pm |
 |
@VatqLu $EGRX Waiting for Buy signal . https://t.co/xFVG3zRfR7 January 25th 2022, 2:01pm |
 |
@Ba4Saso $EGRX Waiting for Buy signal. Chart by https://t.co/z6vAd7dl0q https://t.co/bcZxqkG0Qk January 24th 2022, 5:01pm |
|
@TortozaLeandro $EGRX Awaiting for Buy signal on EGRX with https://t.co/BVorhZSlcz https://t.co/HJgKYlTlNO January 24th 2022, 2:01pm |
|
@TortozaLeandro $EGRX Awaiting for Buy signal on EGRX with https://t.co/BVorhZSlcz https://t.co/T2VFZPLYUJ January 21st 2022, 7:01pm |
 |
@MaiteMerenda $EGRX Bullish pattern forming. Chart by https://t.co/t5kOjgsWN3 https://t.co/tFDtzV7GK2 January 20th 2022, 6:01pm |
|
@TortozaLeandro $EGRX Awaiting for Buy signal on EGRX with https://t.co/BVorhZSlcz https://t.co/l9r759WiLs January 19th 2022, 7:01pm |
 |
@A1Syad $EGRX Awaiting Buy Signal. Chart by https://t.co/1MjnDHV7ua https://t.co/8R8DkMD3Dr January 19th 2022, 12:01pm |
 |
@newsfilterio Eagle Pharmaceuticals Announces Commercial Availability of Vasopressin $EGRX https://t.co/ZKQRA45K00 January 19th 2022, 7:01am |
|
@TortozaLeandro $EGRX Awaiting for Buy signal on EGRX with https://t.co/BVorhZSlcz https://t.co/tZZLBc9QqN January 18th 2022, 8:01pm |
 |
@ShockExchange Courts Should Uphold Injunction Against Eagle Pharma's Generic Vasostrict https://t.co/bUlVQoolgm $EGRX $ENDP January 18th 2022, 4:01pm |
 |
@MarcJacksonLA $EGRX Eagle Pharmaceuticals Announces Commercial Availability of Vasopressin https://t.co/kTDwdN89NM January 18th 2022, 2:01pm |
 |
@Briefingcom $EGRX: Eagle Pharma announced the commercial availability of its recently approved product, vasopressin, an A-rated… https://t.co/U37nAU9yT9 January 18th 2022, 1:01pm |
 |
@FlashAlert_me $EGRX [15s. delayed] filed form 8-K on January 18, 07:00:21 https://t.co/CHpEytVxEw January 18th 2022, 12:01pm |
 |
@investor_feed $EGRX 8-K Eagle Pharmaceuticals (18 Jan, 7:00am) ? Eagle Pharmaceuticals Announces Commercial Availability of… https://t.co/Escq3iofJC January 18th 2022, 12:01pm |
 |
@Market_Newswire $EGRX SEC Filing: 8-K Other Events - EAGLE PHARMACEUTICALS, INC. (0000827871) January 18 https://t.co/NndioyZpD5 January 18th 2022, 12:01pm |
 |
@StckPro $EGRX NEW ARTICLE : Eagle Pharmaceuticals Announces Commercial Availability of Vasopressin https://t.co/evjzAep8Qv… https://t.co/F0RYKGHQLq January 18th 2022, 11:01am |
 |
@newsinthemarket Eagle Pharmaceuticals announces commercial availability of vasopressin $EGRX January 18th 2022, 11:01am |
|
@FlashAlert_me $EGRX [15s. delayed]: Issued Press Release on January 18, 06:50:00: Eagle Pharmaceuticals Announces Commercial Avai… https://t.co/llo1uvEyfj January 18th 2022, 11:01am |
 |
@phasefivebot $EGRX Eagle Pharmaceuticals Announces Commercial Availability of Vasopressin https://t.co/Pp5hxcDzTx January 18th 2022, 11:01am |
 |
@stockbull4life $EGRX ? Eagle Pharmaceuticals Announces Commercial Availability of Vasopressin January 18th 2022, 11:01am |
 |
@StockNewsBot2 $EGRX Eagle Pharmaceuticals Announces Commercial Availability of Vasopressin https://t.co/cirGXVTzSQ January 18th 2022, 11:01am |
 |
@mikalche $EGRX Eagle Pharmaceuticals Announces Commercial Availability of Vasopressin January 18th 2022, 11:01am |
 |
@stock_titan $EGRX Eagle Pharmaceuticals Announces Commercial Availability of Vasopressin https://t.co/TaQiXAvGP8 January 18th 2022, 11:01am |
 |
@WebChronicleTo1 $EGRX Eagle Pharmaceuticals Announces Commercial Availability of Vasopressin https://t.co/9eqk4SNceU January 18th 2022, 11:01am |
 |
@Tickeron $EGRX's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds f… https://t.co/68gdwWqd9S January 18th 2022, 5:01am |
|
@Tickeron $EGRX's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/NzIiLW5TtD January 18th 2022, 1:01am |
|
@Ba4Saso $EGRX Bullish pattern building. Chart by https://t.co/z6vAd7dl0q https://t.co/D2lLonAhpK January 17th 2022, 4:01pm |
|
@MaiteMerenda $EGRX Awaiting Buy Signal. Free Trial at https://t.co/t5kOjgsWN3 https://t.co/RyOQ18VtBl January 17th 2022, 12:01pm |
|
@Tickeron $EGRX's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/KkQ0CrIsCD January 16th 2022, 1:01am |
 |
@ShogunTrade $EGRX Awaiting Buy Signal. Free 7 Day Trial at https://t.co/6vnULU2sSf https://t.co/GrsokTfd14 January 15th 2022, 8:01pm |
|
@TortozaLeandro $EGRX Awaiting for Buy signal on EGRX with https://t.co/BVorhZSlcz https://t.co/IVaxOXYKv6 January 15th 2022, 6:01pm |
|
@TortozaLeandro $EGRX Awaiting for Buy signal on EGRX with https://t.co/BVorhZSlcz https://t.co/iFGeAWcVxO January 14th 2022, 5:01pm |
|
@ShockExchange Launching generic Vasostrict on appeal could bankrupt Eagle Pharma https://t.co/ZubE5mkAaE $EGRX $ENDP #vasostrict January 14th 2022, 5:01pm |
 |
@invescent $EGRX Data indicates that the overall analyst sentiment for EGRX is bullish. Simplify the way you research stock… https://t.co/u3z3Usu7Mz January 13th 2022, 5:01pm |
 |
@SismasStock $EGRX waiting for Buy signal on EGRX with https://t.co/WNHrn3Pr7t https://t.co/Y8Hp39VpyX January 13th 2022, 4:01pm |
|
@TortozaLeandro $EGRX Awaiting for Buy signal on EGRX with https://t.co/BVorhZST27 https://t.co/nRE6Pf535g January 13th 2022, 4:01pm |
|
@MaiteMerenda $EGRX Awaiting Buy Signal. Stock Trading Ideas by https://t.co/t5kOjgsWN3 https://t.co/NgWAdmsy0s January 12th 2022, 2:01pm |
|
@Tickeron How does this affect your portfolio? $EGRX price moved above its 50-day Moving Average. #EaglePharmaceuticals… https://t.co/QAX57IkIIN January 12th 2022, 4:01am |
 |
@InsiderAlerts4U $EGRX: New Insider Filing on EAGLE PHARMACEUTICALS, INC.'s Chief Financial Officer BRIAN JOSEPH CAHILL: https://t.co/kBDJtQeJvq January 12th 2022, 3:01am |
 |
@LevFinCynic Closed remaining half of $EGRX short at $51.5. Tiny profits, but will take it for a quick 15 day trade. https://t.co/LKE1nOPQBI January 12th 2022, 1:01am |
|
@investor_feed $EGRX 8-K Eagle Pharmaceuticals (11 Jan, 11:45am) ? Regulation FD Disclosure; Financial Statements and Exhibit… https://t.co/oQsIW3U0P7 January 11th 2022, 4:01pm |
|
@FlashAlert_me $EGRX [15s. delayed] filed form 8-K on January 11, 11:45:58 https://t.co/VXcGkWqEIK January 11th 2022, 4:01pm |
|
@Market_Newswire $EGRX SEC Filing: 8-K Reg FD - EAGLE PHARMACEUTICALS, INC. (0000827871) January 11 https://t.co/uqNVQ77143 January 11th 2022, 4:01pm |
|
@MaiteMerenda $EGRX Almost ripe for a run Chart by https://t.co/t5kOjgsWN3 https://t.co/LAkfVDZluk January 11th 2022, 4:01pm |
|
@TortozaLeandro $EGRX Awaiting for Buy signal on EGRX with https://t.co/BVorhZSlcz https://t.co/9GoLyEZCBl January 11th 2022, 3:01pm |
|
@A1Syad $EGRX Awaiting Buy Signal. Chart by https://t.co/1MjnDHV7ua https://t.co/k3aUpMVsyZ January 11th 2022, 1:01pm |
|
@InsiderAlerts4U $EGRX: New Insider Filing on EAGLE PHARMACEUTICALS, INC.'s Chief Financial Officer BRIAN JOSEPH CAHILL: https://t.co/1KwYOQ0Wt1 January 11th 2022, 12:01pm |
 |
@ShortAlgoKing $EGRX Short pattern building. Chart by https://t.co/qchl9O5K2n https://t.co/0WYZqIemue January 10th 2022, 7:01pm |
|
@TortozaLeandro $EGRX Awaiting for Buy signal on EGRX with https://t.co/BVorhZSlcz https://t.co/JMihF7LeyM January 10th 2022, 3:01pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?